1984
DOI: 10.1007/978-3-642-82249-0_1
|View full text |Cite
|
Sign up to set email alerts
|

Current Understanding of Virus Etiology in Leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1984
1984
1997
1997

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 162 publications
0
2
0
Order By: Relevance
“…A comparison should be made between the retrovirusrelated human placental p30 protein and the predicted protein product of the human endogenous retrovirus p30 gag gene (14,15), the SSAV p28 cross-reactive protein found in some patients with leukemia (35,45,46) or system lupus erythematosus (27,34,43), and the p24 core protein of the exogenous human T-cell leukemia virus (44).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A comparison should be made between the retrovirusrelated human placental p30 protein and the predicted protein product of the human endogenous retrovirus p30 gag gene (14,15), the SSAV p28 cross-reactive protein found in some patients with leukemia (35,45,46) or system lupus erythematosus (27,34,43), and the p24 core protein of the exogenous human T-cell leukemia virus (44).…”
Section: Discussionmentioning
confidence: 99%
“…The antibody dilution titers of antiretrovirus p30 serums were determined by indirect enzymoimmunoassay as described (34). Competition enzymoimmunoassays were developed as described (35) for SSAV/GaLV p28 by using GaLV target and goat IgG anti-SSAV p28 and for BEV/RD-114 p28 by using BEV target and goat IgG anti-RD-114 p28. 1-4), anti-RD-114 p28 serum (lanes 5-7), and normal goat serum (lanes 8-10) against 50 ng of SSAV (lanes 1,6, and 8), 50 ng of GaLV (lane 2), 50 ng of RD-114 (lanes 3, 5, and 9), and 200 ng of MuLV (lanes 4, 7, and 10).…”
Section: Methodsmentioning
confidence: 99%